[1]
|
Zimmet, P., Alberti, K.G. and Shaw, J. (2001) Global and social implication of the diabetes epidemic. Nature, 414, 782-787. doi:10.1038/414782a
|
[2]
|
American Diabetes Association. (2008) Standards of medical care in diabetes. Diabetes Care, 31, S12-S54.
doi:10.2337/dc08-S012
|
[3]
|
Task Force Members. (2007) Guidelines on diabetes, prediabetes and cardiovascular diseases: Executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) European Heart Journal, 28, 88-136
|
[4]
|
UK Prospective Diabetes Study (UKPDS) Group. (1998) Intensive blood glucose control with sulfonylurea or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). The Lancet, 352, 837-853.
doi:10.1016/S0140-6736(98)07019-6
|
[5]
|
Gaede, P., et al. (2008) Effect of a multifactorial intervention on mortality of type 2 diabetes. The New England Journal of Medicine, 358, 580-591.
doi:10.1056/NEJMoa0706245
|
[6]
|
White, J.R. and Campbell, R.K. (2009) Overview of medications used to treat type 2 diabetes. In: White, J.R. and Campbell, R.K., Eds., ADA/PDR Medication for the Treatment of Diabetes, The Healthcare business of Thomson Reuters, Montvale, 5-15.
|
[7]
|
Nathan, D.M., Buse, J.B., Davidson, M.B., et al. (2006) Management of hyperglycemia in type 2 diabetes mellitus: A consensus algorithm for the initiation and adjustment of therapy. In: White, J.R. and Campbell, R.K., Eds., ADA/PDR Medication for the Treatment of Diabetes, The Healthcare business of Thomson Reuters, Montvale, 17-31.
|
[8]
|
Warram, J.H., Martin, B.C., et al. (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type 2 diabetes in the offspring of diabetic parents. Annals of International Medicine, 113, 909-915.
|
[9]
|
Lebovitz, H.E. (2002) Rational for and role of thiazolidinediones in type 2 diabetes mellitus. The American Journal of cardiology, 90, 34-41.
doi:10.1016/S0002-9149(02)02557-2
|
[10]
|
Bailey, C.J. (2009) Metformin. In: Lebovitz, H.E., Ed., Therapy for Diabetes Mellitus and Related Disorders, 5th Edition, American Diabetes Association, Alexandria, 235-253.
|
[11]
|
Lebovitz, H.E. (2009) Thiazolidinedione. In: Lebovitz, H.E., Ed., Therapy for Diabetes Mellitus and Related Disorders, 5th Edition, American Diabetes Association, Alexandria, 260-272.
|
[12]
|
Buse, J.B., Polonsky, K.S. and Burant, C.F. () Type 2 diabetes mellitus. In: Kronenberg, H.M., Melmed, S., Polanski, K.S., Larsen, P.R., Eds., William’s Textbook of Endocrinology, 11th Edition, Saunders, Philadelphia, 1330-1389.
|
[13]
|
Klezig, H., kober, G., Matter, C., et al. (1999) Sulfonylurea and ischemic preconditioning; a double blind placebo controlled evaluation of glimepiride and glibenclamide. European Heart Journal, 20, 439-446.
doi:10.1053/euhj.1998.1242
|
[14]
|
Riddle, M.C. (2003) Editorial sulfonylureas differ in effects on ischemic preconditioning—Is it time to retire glyburide? The Journal of Clinical Endocrinology Metabolism, 88, 528-530. doi:10.1210/jc.2002-021971
|
[15]
|
Lebovitz, H.E. (2010) Management of hyperglycemia with oral antihyperglycemic agents in type 2 diabetes. In: Khan, C.R., Weir, G.C., King, G.L., Jacobson, A.M., Moses, A.C., Smith, R.J. Eds., Joslin’s Diabetes Mellitus, 14th Edition, Wolters Kluwer Pvt Ltd., New Delhi, 685-710.
|
[16]
|
UK Prospective Diabetes Study (UKPDS) Group (2005) Association of glycemia with micro vascular and macro vascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. British Medical Journal, 32, 405-412.
|
[17]
|
Vague, P. and Moulin, J.P. (1982) The defective glucose sensitivity of the β-cell in noninsulin dependent diabetes: Improvement after twenty hours normoglycemia. Metabolism, 31, 139-142.
doi:10.1016/0026-0495(82)90125-1
|
[18]
|
Nathan, D.M. (2010) Relationship between metabolic control and long-term complications of diabetes. In: Khan, C.R., Weir, G.C., King, G.L., Jacobson, A.M., Moses, A.C., Smith, R.J. Eds., Joslin’s Diabetes Mellitus, 14th Edition, New Delhi, Wolters Kluwer Pvt Ltd., 809-821.
|
[19]
|
Rothman, D.L., Magnusson, I., Katz, L.D., et al. (1991) Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting human with 13C NMR. Science, 254, 573-576.
|
[20]
|
Long, Y.C. and Zierath, J.R. (2006) AMP-activated protein kinase signaling in metabolic regulation. The Journal of Clinical Investigation, 16, 1776-1783.
doi:10.1172/JCI29044
|